METAGENOMI THERAPEUTICS INC (MGX) Stock Cash Flow
NASDAQ:MGX • US59102M1045
Current stock price
1.41 USD
+0.03 (+2.17%)
At close:
1.38 USD
-0.03 (-2.13%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -87.87M | -78.06M | -68.25M | -43.59M | -21.44M | |||
| Depreciation Amortization | 5.32M | 5.41M | 4.21M | 1.73M | 387.00K | |||
| Change In Working Capital | -22.09M | -59.67M | -26.43M | 69.49M | 46.26M | |||
| Taxes Paid | -2.24M | 3.50M | N/A | N/A | N/A | |||
| Other non cash items | 15.75M | 23.25M | -932.00K | 2.10M | -943.00K | |||
| OPERATING CASH FLOW | -88.89M | -109.07M | -91.41M | 29.72M | 24.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -574.00K | -3.11M | -9.81M | -13.98M | -2.90M | |||
| Other Investing Activity | 104.10M | -85.04M | 55.55M | -108.22M | -71.41M | |||
| INVESTING CASH FLOW | 103.53M | -88.16M | 45.73M | -122.20M | -74.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 29.97M | |||
| Stock Issued/Repurchased | 202.00K | 84.01M | 4.29M | 239.59M | 9.95M | |||
| Other Financing Activity | -558.00K | N/A | -3.28M | N/A | N/A | |||
| FINANCING CASH FLOW | -356.00K | 84.01M | 1.01M | 239.59M | 39.92M | |||
| CHANGE IN CASH | 14.28M | -113.22M | -44.66M | 147.12M | -10.14M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -88.89M | -109.07M | -91.41M | 29.72M | 24.26M | |||
| Capital Expenditure | -574.00K | -3.11M | -9.81M | -13.98M | -2.90M | |||
| FREE CASH FLOW | -89.47M | -112.19M | -101.22M | 15.75M | 21.35M | |||
All data in USD